Needle-free drug delivery market growing; Rosetta Genomics collaborates with Admera Health;

> The global needle-free drug delivery device market exceeds $4 billion, according to a market research report by Transparency Market Research. More

> RNA therapeutics company Rosetta Genomics announced a collaboration with global genomics company Admera Health. More

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.